#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	14338	16S	1529	1529	100.0	16S.l6.c30.ctg.1	2007	707.8	1	SNP	n	C1184T	0	.	.	1184	1184	C	1409	1409	C	840	C	769	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	14338	16S	1529	1529	100.0	16S.l6.c30.ctg.1	2007	707.8	0	HET	.	.	.	C207T	.	207	207	C	432	432	C	796	C,T	580,154	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26586	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3463	765.0	0	.	n	.	0	T695C	SNP	695	695	T	1017	1017	C	808	C,T	736,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26586	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3463	765.0	0	.	n	.	0	A1638G	SNP	1638	1638	A	1960	1960	G	880	G	816	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26586	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3463	765.0	0	.	n	.	0	T1971C	SNP	1971	1971	T	2293	2293	C	846	C	772	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26586	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3463	765.0	1	SNP	n	A2045G	0	.	.	2045	2045	A	2367	2367	A	896	A	843	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26586	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3463	765.0	1	SNP	n	C2597T	0	.	.	2597	2597	C	2919	2919	C	797	C,A	734,2	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_M_01364c	folP.WHO_M_01364c	1	1	539	1980	folP	852	852	99.77	folP.l15.c4.ctg.1	1403	139.4	0	.	p	.	0	S68P	NONSYN	202	204	TCG	414	416	CCG	201;203;201	C;C;G	181;184;182	.	.
folP.WHO_M_01364c	folP.WHO_M_01364c	1	1	539	1980	folP	852	852	99.77	folP.l15.c4.ctg.1	1403	139.4	0	.	p	.	0	A204V	NONSYN	610	612	GCA	822	824	GTA	182;184;186	G;T,C;A	168;171,1;172	.	.
folP.WHO_M_01364c	folP.WHO_M_01364c	1	1	539	1980	folP	852	852	99.77	folP.l15.c4.ctg.1	1403	139.4	1	SNP	p	R228S	1	.	.	682	684	AGC	894	896	AGC	210;209;207	A;G;C	195;194;191	folP.WHO_M_01364c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5164	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3392	152.0	1	SNP	p	S91F	1	.	.	271	273	TTC	589	591	TTC	178;177;176	T;T;C	164;165;162	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5164	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3392	152.0	1	SNP	p	G95N	0	.	.	283	285	GGC	601	603	GGC	164;165;166	G;G;C	152;150;152	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5164	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3392	152.0	1	SNP	p	D95G	1	.	.	283	285	GGC	601	603	GGC	164;165;166	G;G;C	152;150;152	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	27	1736	mtrR	633	633	100.0	mtrR.l15.c17.ctg.1	1326	130.5	1	SNP	p	G45D	0	.	.	133	135	GGC	482	484	GGC	233;229;230	G;G;C	208;203;205	mtrR.WHO_Y_01506:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	932	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	941	98.3	0	.	n	.	0	A197.	DEL	197	197	A	486	486	A	224	A	209	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5080	parC	2304	2304	100.0	parC.l6.c30.ctg.1	2979	169.9	1	SNP	p	D86N	0	.	.	256	258	GAC	608	610	GAC	211;208;208	G;A;C	192;187;193	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5080	parC	2304	2304	100.0	parC.l6.c30.ctg.1	2979	169.9	1	SNP	p	S87R	1	.	.	259	261	CGT	611	613	CGT	208;210;208	C;G;T	190;190;189	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5080	parC	2304	2304	100.0	parC.l6.c30.ctg.1	2979	169.9	1	SNP	p	R87W	0	.	.	259	261	CGT	611	613	CGT	208;210;208	C;G;T	190;190;189	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5080	parC	2304	2304	100.0	parC.l6.c30.ctg.1	2979	169.9	1	SNP	p	R87I	0	.	.	259	261	CGT	611	613	CGT	208;210;208	C;G;T	190;190;189	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5080	parC	2304	2304	100.0	parC.l6.c30.ctg.1	2979	169.9	1	SNP	p	S88P	0	.	.	262	264	TCC	614	616	TCC	207;211;209	T;C;C	189;190;191	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4474	parE	1986	1986	100.0	parE.l15.c30.ctg.1	2630	169.5	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1471	1473	GGC	216;215;217	G,A;G;C	191,1;194;195	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	3998	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2415	164.8	1	SNP	p	A311V	0	.	.	931	933	GCC	1302	1304	GCC	213;214;216	G;C,A;C	195;198,1;199	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3998	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2415	164.8	1	SNP	p	I312M	1	.	.	934	936	ATG	1305	1307	ATG	216;216;215	A;T;G	200;201;199	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3998	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2415	164.8	1	SNP	p	T316P	0	.	.	946	948	ACC	1317	1319	ACC	213;216;214	A;C;C	196;198;197	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3998	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2415	164.8	1	SNP	p	V316T	1	.	.	946	948	ACC	1317	1319	ACC	213;216;214	A;C;C	196;198;197	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3998	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2415	164.8	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1818	1820	ACC	203;205;209	A;C;C	185;191;194	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3998	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2415	164.8	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1872	1874	GCG	210;209;209	G;C;G	193;196;196	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3998	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2415	164.8	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1872	1874	GCG	210;209;209	G;C;G	193;196;196	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3998	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2415	164.8	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1995	1997	GGT	176;175;172	G;G;T	161;159;156	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3998	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2415	164.8	1	SNP	p	G545S	1	.	.	1633	1635	AGC	2004	2006	AGC	162;158;158	A;G;C	147;146;147	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3998	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2415	164.8	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2022	2024	CCG	139;140;139	C,G;C;G	100,9;102;102	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5656	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3002	187.7	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1637	1639	CCG	188;187;183	C,T;C,T;G	165,1;169,1;160	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2520	porA	1146	1146	99.91	porA.l15.c17.ctg.1	1627	153.4	0	.	p	.	0	M83fs	FSHIFT	247	247	A	465	465	C	182	C	170	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2508	porB1b	1038	1038	100.0	porB1b.l15.c4.ctg.1	1733	143.9	1	SNP	p	G120K	1	.	.	358	360	AAG	790	792	AAG	206;207;209	A;A;G	196;197;196	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2508	porB1b	1038	1038	100.0	porB1b.l15.c4.ctg.1	1733	143.9	1	SNP	p	N121D	0	.	.	361	363	AAC	793	795	AAC	208;207;206	A;A;C	195;194;193	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2508	porB1b	1038	1038	100.0	porB1b.l15.c4.ctg.1	1733	143.9	1	SNP	p	A121N	1	.	.	361	363	AAC	793	795	AAC	208;207;206	A;A;C	195;194;193	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	10176	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4766	213.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1092	rpsJ	312	312	100.0	rpsJ.l15.c30.ctg.1	1019	106.4	1	SNP	p	V57M	1	.	.	169	171	ATG	458	460	ATG	219;219;221	A;T;G	208;204;208	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
